U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C24H44O6
Molecular Weight 428.6026
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of SORBITAN MONOOLEATE

SMILES

CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O

InChI

InChIKey=NWGKJDSIEKMTRX-AAZCQSIUSA-N
InChI=1S/C24H44O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-22(27)29-19-21(26)24-23(28)20(25)18-30-24/h9-10,20-21,23-26,28H,2-8,11-19H2,1H3/b10-9-/t20-,21+,23+,24+/m0/s1

HIDE SMILES / InChI

Molecular Formula C24H44O6
Molecular Weight 428.6026
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 1
Optical Activity UNSPECIFIED

Sorbitan monooleate (Span 80) is a partial oleate ester of sorbitol and its mono- and dianhydrides. Sorbitan Monooleate is a nonionic emulsifier and surfactant and used in cosmetics and foods. It is a food additive with the E number E495. Span 80 was suitable as surfactant in the preparation of Poly(divinylbenzene) emulsion-derived (PolyHIPE) solid foam. Anionic nanoparticles based on Span 80 as low-cost, simple and efficient non-viral gene-transfection systems. Sorbitan monooleate is approved by FDA to be used as an emulsifier in polymer dispersions that are used in the clarification of cane or beet sugar juice or liquor in an amount not to exceed 7.5 percent by weight in the final polymer dispersion. The additive is used in an amount not to exceed 0.70 part per million in sugar juice and 1.4 parts per million in sugar liquor.

Approval Year

PubMed

PubMed

TitleDatePubMed
Copper complexed polymer carriers for IgG adsorption.
2010-12-01
The effect of component of microemulsion for transdermal delivery of nicardipine hydrochloride.
2010-12
Evaluation of a new oil adjuvant for use in peptide-based cancer vaccination.
2010-10
Development and evaluation of emulsions from Carapa guianensis (Andiroba) oil.
2010-09
A randomised, assessor blind, parallel group comparative efficacy trial of three products for the treatment of head lice in children--melaleuca oil and lavender oil, pyrethrins and piperonyl butoxide, and a "suffocation" product.
2010-08-20
Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration.
2010-08
Effect of surfactant concentration on transdermal lidocaine delivery with linker microemulsions.
2010-06-15
Removal of 241Am from aqueous nitrate solutions by liquid surfactant membrane containing 2-ethylhexyl phosphonic acid mono-2-ethylhexyl ester as ion carrier.
2010-06
Pickering emulsions stabilized by a lipophilic surfactant and hydrophilic platelike particles.
2010-04-20
In vitro and in vivo anti-tumor effects of novel Span 80 vesicles containing immobilized Eucheuma serra agglutinin.
2010-04-15
Effect of counter-ions and penetration enhancers on the skin permeation of flurbiprofen.
2010-04
New approach to hydrophobic cyanine-type photosensitizer delivery using polymeric oil-cored nanocarriers: hemolytic activity, in vitro cytotoxicity and localization in cancer cells.
2010-03-18
Studies on the evolution of ZnO morphologies in a thermohydrolysis technique and evaluation of their functional properties.
2010-03-15
Liposomes in double-emulsion globules.
2010-03-02
Tamoxifen-encapsulated vesicular systems: cytotoxicity evaluation in human epidermal keratinocyte cell line.
2010-03
Evaluation of lung tolerance of ethanol, propylene glycol, and sorbitan monooleate as solvents in medical aerosols.
2010-02
Study on ultrasonically assisted emulsification and recovery of copper(II) from wastewater using an emulsion liquid membrane process.
2010-02
Solubility of ocular therapeutic agents in self-emulsifying oils. I. Self-emulsifying oils for ocular drug delivery: solubility of indomethacin, aciclovir and hydrocortisone.
2010-01-07
Photoprotective potential of emulsions formulated with Buriti oil (Mauritia flexuosa) against UV irradiation on keratinocytes and fibroblasts cell lines.
2010-01
Preparation and evaluation of fast-release mephenamic acid microspheres.
2010
Sorbitan monooleate and poly(L-lactide-co-epsilon-caprolactone) electrospun nanofibers for endothelial cell interactions.
2009-12
A metal-chelate affinity reverse micellar system for protein extraction.
2009-10-16
Structure of high internal phase aqueous-in-oil emulsions and related inverse micelle solutions. 3. Variation of surfactant.
2009-09-10
Structure of high internal phase aqueous-in-oil emulsions and related inverse micelle solutions. 4. Surfactant mixtures.
2009-09-10
Optimization of process parameters for the extraction of chromium (VI) by emulsion liquid membrane using response surface methodology.
2009-08-30
The influence of non-ionic surfactants on the rheological properties of drug/microcrystalline cellulose/water mixtures and their use in the preparation and drug release performance of pellets prepared by extrusion/spheronization.
2009-06-28
Distribution of Sorbitan Monooleate in poly(L-lactide-co-epsilon-caprolactone) nanofibers from emulsion electrospinning.
2009-03-01
Sorbitan sesquioleate, a common emulsifier in topical corticosteroids, is an important contact allergen.
2009-01-13
Investigation on processing variables for the preparation of fluconazole-loaded ethyl cellulose microspheres by modified multiple emulsion technique.
2009
Fast dissolving films made of maltodextrins.
2008-11
Temperature-sensitive nonionic vesicles prepared from Span 80 (sorbitan monooleate).
2008-10-07
The preparation of pellets containing non-ionic surfactants by extrusion/spheronization.
2008-09-01
Intermolecular interactions and morphology of aqueous polymer/surfactant mixtures containing cationic chitosan and nonionic sorbitan esters.
2008-08
Novel method for obtaining homogeneous giant vesicles from a monodisperse water-in-oil emulsion prepared with a microfluidic device.
2008-05-06
Coprocessing via spray drying as a formulation platform to improve the compactability of various drugs.
2008-05
Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer.
2008-04-02
Memory-improving effect of formulation-MSS by activation of hippocampal MAPK/ERK signaling pathway in rats.
2008-03-31
Extraction of Co(II) from aqueous solution using emulsion liquid membrane.
2008-03-01
Improvement of biodesulfurization activity of alginate immobilized cells in biphasic systems.
2008-03
Process design applied to optimise a directly compressible powder produced via a continuous manufacturing process.
2008-03
Linker-based lecithin microemulsions for transdermal delivery of lidocaine.
2008-02-12
Formulation and evaluation of flurbiprofen microemulsion.
2008-01
Permeation studies of indomethacin from different emulsions for nasal delivery and their possible anti-inflammatory effects.
2008
Polymer drop breakup in microchannels.
2007-12
Preparation of tiny biodegradable capsules using electrocapillary emulsification.
2007-12
Comparison of different water/oil microemulsions containing diclofenac sodium: preparation, characterization, release rate, and skin irritation studies.
2007-11-02
Effect of ciprofloxacin and chloramphenicol on humoral immune response elicited by bovine albumin encapsulated in niosomes.
2007-08
Direct measurement of critical nucleus size in confined volumes.
2007-06-19
Black cohosh and St. John's wort (GYNO-Plus) for climacteric symptoms.
2007-04-30
Controlled release of methotrexate from w/o microemulsion and its in vitro antitumor activity.
2007-04

Sample Use Guides

Under the optimal conditions in the fed-batch culture with 5 g/l Sorbitan monooleate (Span 80), the cell mass and the concentration, content, and productivity of retinal were 24.7 g/l, 600 mg/l, 24.3mg/g-cells, and 18 mg l(-1)h(-1) after 33 h, respectively.
Substance Class Chemical
Created
by admin
on Wed Apr 02 08:40:15 GMT 2025
Edited
by admin
on Wed Apr 02 08:40:15 GMT 2025
Record UNII
06XEA2VD56
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SORBITAN OLEATE
EP   INCI   INN   MART.  
INN   INCI  
Preferred Name English
SORBITAN MONOOLEATE
FCC   HSDB   II   USAN   VANDF  
USAN  
Official Name English
sorbitan oleate [INN]
Common Name English
INS NO.494
Code English
SORBITAN, MONO-9-OCTADECENOATE
Common Name English
SORBITAN MONO-OLETAE
WHO-DD  
Common Name English
SORBITAN MONOOLEATE [FCC]
Common Name English
SORBITAN MONOOLEATE [VANDF]
Common Name English
ARLACEL 80
Brand Name English
SORBITAN, MONO-(9Z)-9-OCTADECENOATE
Common Name English
NSC-406239
Code English
SPAN 80
Brand Name English
SORBITAN MONOOLEATE [II]
Common Name English
SORBITAN MONOOLEATE [USAN]
Common Name English
D-GLUCITOL, 1,4-ANHYDRO-, 6-(9-OCTADECENOATE)
Common Name English
SORBITAN ESTERS SORBITAN OLEATE [MI]
Common Name English
SORBITAN OLEATE [EP MONOGRAPH]
Common Name English
INS-494
Code English
ANHYDROSORBITOL MONOOLEATE
Common Name English
E-494
Code English
SORBITAN OLEATE [MART.]
Common Name English
Sorbitan mono-oleate [WHO-DD]
Common Name English
1,4-ANHYDRO-D-GLUCITOL, 6-(9-OCTADECENOATE
Common Name English
SORBITAN MONOOLEATE [HSDB]
Common Name English
Classification Tree Code System Code
CODEX ALIMENTARIUS (GSFA) INS-494
Created by admin on Wed Apr 02 08:40:15 GMT 2025 , Edited by admin on Wed Apr 02 08:40:15 GMT 2025
CFR 21 CFR 173.75
Created by admin on Wed Apr 02 08:40:15 GMT 2025 , Edited by admin on Wed Apr 02 08:40:15 GMT 2025
JECFA EVALUATION INS-494
Created by admin on Wed Apr 02 08:40:15 GMT 2025 , Edited by admin on Wed Apr 02 08:40:15 GMT 2025
NCI_THESAURUS C83486
Created by admin on Wed Apr 02 08:40:15 GMT 2025 , Edited by admin on Wed Apr 02 08:40:15 GMT 2025
Code System Code Type Description
NSC
406239
Created by admin on Wed Apr 02 08:40:15 GMT 2025 , Edited by admin on Wed Apr 02 08:40:15 GMT 2025
PRIMARY
EVMPD
SUB23477
Created by admin on Wed Apr 02 08:40:15 GMT 2025 , Edited by admin on Wed Apr 02 08:40:15 GMT 2025
PRIMARY
SMS_ID
100000088792
Created by admin on Wed Apr 02 08:40:15 GMT 2025 , Edited by admin on Wed Apr 02 08:40:15 GMT 2025
PRIMARY
RXCUI
1363056
Created by admin on Wed Apr 02 08:40:15 GMT 2025 , Edited by admin on Wed Apr 02 08:40:15 GMT 2025
PRIMARY RxNorm
ECHA (EC/EINECS)
215-665-4
Created by admin on Wed Apr 02 08:40:15 GMT 2025 , Edited by admin on Wed Apr 02 08:40:15 GMT 2025
PRIMARY
MERCK INDEX
m10120
Created by admin on Wed Apr 02 08:40:15 GMT 2025 , Edited by admin on Wed Apr 02 08:40:15 GMT 2025
PRIMARY Merck Index
CAS
1338-43-8
Created by admin on Wed Apr 02 08:40:15 GMT 2025 , Edited by admin on Wed Apr 02 08:40:15 GMT 2025
PRIMARY
MESH
C018665
Created by admin on Wed Apr 02 08:40:15 GMT 2025 , Edited by admin on Wed Apr 02 08:40:15 GMT 2025
PRIMARY
ChEMBL
CHEMBL2107274
Created by admin on Wed Apr 02 08:40:15 GMT 2025 , Edited by admin on Wed Apr 02 08:40:15 GMT 2025
PRIMARY
INN
1875
Created by admin on Wed Apr 02 08:40:15 GMT 2025 , Edited by admin on Wed Apr 02 08:40:15 GMT 2025
PRIMARY
FDA UNII
06XEA2VD56
Created by admin on Wed Apr 02 08:40:15 GMT 2025 , Edited by admin on Wed Apr 02 08:40:15 GMT 2025
PRIMARY
EPA CompTox
DTXSID6027397
Created by admin on Wed Apr 02 08:40:15 GMT 2025 , Edited by admin on Wed Apr 02 08:40:15 GMT 2025
PRIMARY
WIKIPEDIA
Sorbitan monooleate
Created by admin on Wed Apr 02 08:40:15 GMT 2025 , Edited by admin on Wed Apr 02 08:40:15 GMT 2025
PRIMARY
EVMPD
SUB10598MIG
Created by admin on Wed Apr 02 08:40:15 GMT 2025 , Edited by admin on Wed Apr 02 08:40:15 GMT 2025
PRIMARY
HSDB
5822
Created by admin on Wed Apr 02 08:40:15 GMT 2025 , Edited by admin on Wed Apr 02 08:40:15 GMT 2025
PRIMARY
PUBCHEM
9920342
Created by admin on Wed Apr 02 08:40:15 GMT 2025 , Edited by admin on Wed Apr 02 08:40:15 GMT 2025
PRIMARY
DAILYMED
06XEA2VD56
Created by admin on Wed Apr 02 08:40:15 GMT 2025 , Edited by admin on Wed Apr 02 08:40:15 GMT 2025
PRIMARY
NCI_THESAURUS
C75654
Created by admin on Wed Apr 02 08:40:15 GMT 2025 , Edited by admin on Wed Apr 02 08:40:15 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY